Why some photoreceptors die, while others remain dormant: Lessons from RPE65 and LRAT associated retinal dystrophies

Ophthalmic Genetics

Volumn 32, Issue 2, 2011, Pages 126-128

  Koenekoop, Robert K ^a,b  

^a MCGILL UNIVERSITY   (Canada)

^b MONTREAL CHILDREN S HOSPITAL   (Canada)

Author keywords

apoptosis; cell death; photoreceptors; retinal dystrophies

Indexed keywords

PROTEIN BAX; PROTEIN BCL 2;

APOPTOSIS; GENE; LRAT GENE; PHOTORECEPTOR; PHOTOTRANSDUCTION; PRIORITY JOURNAL; RETINA CONE; RETINA DYSTROPHY; RETINA ROD; REVIEW; RPE65 GENE;

ACYLTRANSFERASES; APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; CARRIER PROTEINS; EYE PROTEINS; HUMANS; MUTATION; PHOTORECEPTOR CELLS, VERTEBRATE; PROTO-ONCOGENE PROTEINS C-BCL-2; RETINAL DYSTROPHIES; VISION, OCULAR;

EID: 79955840582     PISSN: 13816810     EISSN: 17445094     Source Type: Journal    
DOI: 10.3109/13816810.2010.544361     Document Type: Review

References (16)

1. Fan J, Woodruff ML, Cilluffo MC, et al. Rpe65-/-and Lrat-/-mice: comparable models of leber congenital amau-rosis. Invest Ophthalmol Vis Sci. 2008; 49 (6) 2384-2389.
2. Koenekoop RK. An overview of Leber congenital amaurosis: a model to understand human retinal development. Surv Ophthalmol. 2004;49(4):379-398. (Pubitemid 38844798)
3. den Hollander AI, Lopez I, Yzer S, et al. Identifcation of novel mutations in patients with Leber congenital amauro-sis and juvenile RP by genome-wide homozygosity map¬ping with SNP microarrays. Invest Ophthalmol Vis Sci. 2007; 48(12):5690-5698. (Pubitemid 351260873)
4. Koenekoop RK, Lopez I, Der Hollander AI, et al. Genetic testing for retinal dystrophies and dysfunctions: benefts, dilemmas and solutions. Clin Experiment Ophthalmol. 2007;35(5):473-485. (Pubitemid 47162765)
5. Lorenz B, Gyurus P, Preising M, et al. Early-onset severe rod-cone dystrophy in young children with RPE65 muta-tions. Invest Ophthalmol Vis Sci. 2000;41(9):2735-2742. (Pubitemid 30624407)
6. Jacobson SG, Aleman, TS, Cideciyan AV, et al., Identifying photoreceptors in blind eyes caused by RPE65 mutations: Prerequisite for human gene therapy success. Proc Natl Acad Sci USA. 2005;102(17): 6177-6182. (Pubitemid 40594274)
7. Maguire AM, High KA, Auriccio A, et al., Age-dependent effects of RPE65 gene therapy for Leber's congeni-tal amaurosis: a phase 1 dose-escalation trial. Lancet. 2009;374(9701):1597-1605.
8. Lorenz B, Wabbles B, Wegscheider E, et al. Lack of fundus autofuorescence to 488 nanometers from childhood on in patients with early-onset severe retinal dystrophy associ-ated with mutations in RPE65. Ophthalmology. 2004;111(8): 1585-1594. (Pubitemid 39030816)
9. Aguirre GD, Baldwin V, Pearce-Kelling S, et al., Congenital stationary night blindness in the dog: common muta-tion in the RPE65 gene indicates founder effect. Mol Vis. 1998;4:23.
10. Cottet S, Michaut L, Boisset G, et al. Biological characteriza-tion of gene response in Rpe65-/-mouse model of Leber's congenital amaurosis during progression of the disease. FASEB J. 2006;20(12):2036-2049. (Pubitemid 44953903)
11. Woodruff ML, Wang Z, Chung HY, et al., Spontaneous activity of opsin apoprotein is a cause of Leber congenital amaurosis. Nat Genet. 2003;35(2): 158-164. (Pubitemid 37187634)
12. Bainbridge JW. Prospects for gene therapy of inherited reti¬nal disease. Eye (Lond). 2009; 23(10):1898-1903.
13. Cideciyan AV, Kaushal S, Roman A, et al., Human gene therapy for RPE65 isomerase defciency activates the retin-oid cycle of vision but with slow rod kinetics. Proc Natl Acad Sci USA. 2008;105(39):15112-15117.
14. Van Hooser JP, Liang Y, Maeda T, et al., Recovery of visual functions in a mouse model of Leber congenital amaurosis. J Biol Chem. 2002;277(21):19173- 19182. (Pubitemid 34952484)
15. Hamann S, Schorderet DF, Cottet S. Bax-induced apoptosis in Leber's congenital amaurosis: a dual role in rod and cone degeneration. PLoS One. 2009;4(8): e6616.
16. Kaneda K, Kashii S, Kurosawa T. Apoptotic DNA frag¬mentation and upregulation of Bax induced by tran¬sient ischemia of the rat retina. Brain Res. 1999;815(1): 11-20. (Pubitemid 29225219)